Orthopaedics & Sports Medicine  
  Home   |   Site Map   |   Contact Us   |   Links   |   News  
Orthopaedics & Sports Medicine  
Advanced Search
Orthopaedics & Sports Medicine
HomeAbout MethotrexateWhat is it?History of methotrexateHow it worksUse casesDosage & precautionsSide effectsDeciding to start Methotrexate

Print Print Complete Article
View article with questions Hide Questions



Methotrexate.

Last updated Friday, February 11, 2005

Next Page >>

About Methotrexate

What is methotrexate?

Methotrexate (Rheumatrex) is a medicine that is used to treat rheumatoid arthritis (RA), psoriatic arthritis, Reiter's syndrome, and other conditions.

How long have doctors been prescribing methotrexate?

First developed to treat certain types of cancer, methotrexate is routinely used at higher doses as a cancer therapy and is now used at much lower doses to treat rheumatic diseases, like rheumatoid arthritis. Methotrexate has been studied for over 20 years in the treatment of rheumatoid arthritis, and in 1988 was approved for this use in adults by the U.S. Food and Drug Administration (FDA).

How does methotrexate work?

This medicine acts by altering the body's use of folic acid (a vitamin), which is needed for cell growth. Scientists suspect that this interference with folic acid is an important reason for methotrexate's benefit in rheumatoid arthritis. Methotrexate belongs to a group of medicines that are called "second-line therapies" or "disease-modifying anti rheumatic drugs." These drugs may affect the activity of RA to a greater extent than commonly prescribed drugs, such as aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs). Methotrexate is usually taken along with NSAIDs. It may begin to work as early as three to six weeks after beginning treatment.

When is methotrexate usually prescribed?

Methotrexate is used in both children and adults with active or progressive rheumatoid arthritis, although FDA approval is only for adults. It may be prescribed after trying one or more other second-line therapies such as antimalarials or gold salts. It also may be recommended even before starting these drugs. The decision to begin methotrexate will be based upon the opinions of both you and your doctor regarding the progression and activity of your disease. Methotrexate benefits a high percentage of those who use the drug. This improvement includes a decrease in the number of painful and swollen joints, as well as an overall reduction in RA disease activity.  Patients with rheumatoid arthritis who do not respond to methotrexate often are good candidates for surgical reconstruction of their damaged joints, such as total hip arthroplasty, total knee arthroplasty, and total shoulder arthroplasty.


Next Page >>


How useful was this page or article?

This article is rated *0.56 out of 5 stars (4927 ratings).

Not useful at all Not very useful Useful Very useful Extremely useful
* ** *** **** *****
Team Physicians to the UW Huskies Varsity Athletes...And You!
Copyrights and disclaimer  | Privacy statement | Editorial policy
Problems or questions? Contact the webmaster.
Copyright © 2008 University of Washington - Seattle, WA. All rights reserved.